Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Shockwave Medical

Biotech & Life Sciences · Santa Clara, United States · Founded 2009 · IPO 2019 Decacorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$13B
Market cap · 2026
Revenue
$730M
Latest reported FY
EBITDA
$192M
Latest reported FY

Revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque

Investors

8 investors on Shockwave Medical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 7 investors entered at this stage
Deerfield
Ally Bridge Group
Sectoral Asset Management
RA Capital Management
Venrock
Fidelity Investments
Abiomed

Global footprint

Where Shockwave Medical has talent and traffic

AI talent share
0.3% of workforce is AI talent
(5 of 1,541 staff)
Core AI00%
Other AI50.32%
Non-AI workforce1,53699.68%
Workforce by country
21 countries with
team presence
🇺🇸 United States76.8%
🇨🇷 Costa Rica11.3%
🇩🇪 Germany2.2%
🇬🇧 United Kingdom1.7%
🇮🇹 Italy1.6%
Top 5 of 21 shown
Web traffic by country
35K monthly visits
across markets
🇺🇸 United States56.9%
🇯🇵 Japan12.9%
🇮🇳 India6.3%
🇬🇧 United Kingdom5.4%
🇨🇦 Canada4%
Top 5 markets shown

Patent intelligence

$166M patent portfolio · 111 active families

Estimated portfolio value
$166M
1.3% of market cap · smaller than top peer Insulet ($502M)
111 active patent families
Where Shockwave Medical innovates Biomedical engineeringCatheterBlood vesselProsthetic graftCardiac Ventricle

Where Shockwave Medical concentrates vs peers

Each axis is a top-10 topic across Shockwave Medical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Shockwave Medical's 1 investments and acquisitions.

Every disclosed deal where Shockwave Medical appeared as a backer or acquirer, 2023–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across Shockwave Medical's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Shockwave Medical deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Shockwave Medical's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        1 of 1 deals

        Sentiment on X

        What X is saying about Shockwave Medical

        An AI-synthesized read of the highest-engagement posts about Shockwave Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Shockwave Medical on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.